[HTML][HTML] Global epidemiology of cirrhosis—aetiology, trends and predictions
Cirrhosis is an important cause of morbidity and mortality in people with chronic liver
disease worldwide. In 2019, cirrhosis was associated with 2.4% of global deaths. Owing to …
disease worldwide. In 2019, cirrhosis was associated with 2.4% of global deaths. Owing to …
HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: a meta-analysis
Background & Aims There is controversy regarding the overall value of hepatocellular
carcinoma (HCC) surveillance in patients with cirrhosis given the lack of data from …
carcinoma (HCC) surveillance in patients with cirrhosis given the lack of data from …
AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
This guidance document provides an updated approach to the prevention, diagnosis, and
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …
Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2021
Background & Aims Gastrointestinal diseases account for considerable health care use and
expenditures. We estimated the annual burden, costs, and research funding associated with …
expenditures. We estimated the annual burden, costs, and research funding associated with …
Global epidemiology of chronic liver disease
S Cheemerla, M Balakrishnan - Clinical liver disease, 2021 - journals.lww.com
Cirrhosis is a leading cause of mortality and morbidity across the world. It is the 11th leading
cause of death and 15th leading cause of morbidity, accounting for 2.2% of deaths and 1.5 …
cause of death and 15th leading cause of morbidity, accounting for 2.2% of deaths and 1.5 …
[HTML][HTML] Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study
Background & Aims Chronic liver disease (CLD) and cirrhosis are associated with immune
dysregulation, leading to concerns that affected patients may be at risk of adverse outcomes …
dysregulation, leading to concerns that affected patients may be at risk of adverse outcomes …
Epidemiology of hepatocellular carcinoma
KA McGlynn, JL Petrick, HB El‐Serag - Hepatology, 2021 - Wiley Online Library
Liver cancer is a major contributor to the worldwide cancer burden. Incidence rates of this
disease have increased in many countries in recent decades. As the principal histologic type …
disease have increased in many countries in recent decades. As the principal histologic type …
[HTML][HTML] Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
Determine age-specific infection fatality rates for COVID-19 to inform public health policies
and communications that help protect vulnerable age groups. Studies of COVID-19 …
and communications that help protect vulnerable age groups. Studies of COVID-19 …
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry
[1] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality
of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet …
of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet …
The global burden of liver disease
Chronic liver disease (CLD) and its associated complications (cirrhosis and liver cancer)
cause significant mortality, morbidity, and economic burden. Published data from the World …
cause significant mortality, morbidity, and economic burden. Published data from the World …